How GLP-1 Telehealth Visits Actually Work: A Step-by-Step Walkthrough

Getting a GLP-1 prescription used to mean weeks of waiting — scheduling a primary care visit, running labs, waiting for results, then getting a referral to an obesity medicine specialist. Telehealth has compressed that timeline from weeks into days. In 2026, most telehealth platforms can move eligible patients from signup to first dose in 3–7 business days.

But not all virtual GLP-1 visits work the same way. Some platforms use synchronous video consultations with a licensed provider. Others rely on asynchronous questionnaires reviewed by a clinician behind the scenes. Understanding the differences matters — both for the quality of care you receive and the legitimacy of the prescription.

Step 1: The Online Health Assessment

Every legitimate telehealth GLP-1 platform starts with a health intake form. This isn't a formality — it's the clinical foundation your prescriber uses to evaluate whether GLP-1 treatment is appropriate for you. A thorough intake typically covers your current weight and height (to calculate BMI), medical history including cardiovascular conditions and thyroid disorders, current medications and supplements, family history of medullary thyroid carcinoma or MEN 2 syndrome, previous weight loss attempts, and your overall health goals.

The FDA requires that GLP-1 prescribers confirm a patient meets specific criteria: a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Platforms that skip these checks or promise a prescription before evaluation should raise red flags.

Step 2: Provider Consultation

After your intake form is submitted, a licensed prescriber reviews your information. Depending on the platform and your state's telemedicine laws, this review might happen through a live video visit, a phone call, or an asynchronous chart review where the provider evaluates your submitted information and follows up via secure messaging.

The Federation of State Medical Boards requires that telehealth prescribers meet the same standard of care as in-person visits. That means your provider should be asking about contraindications — like a personal or family history of thyroid C-cell tumors — before writing a prescription. They should also discuss the difference between FDA-approved brand-name medications (Wegovy, Zepbound) and compounded alternatives, which are not FDA-approved.

Step 3: Prescription and Pharmacy Fulfillment

If your provider determines that GLP-1 therapy is appropriate, they'll write a prescription. The fulfillment path depends on what type of medication you're prescribed. Brand-name medications like Wegovy or Zepbound are typically sent to a retail or mail-order pharmacy. Compounded semaglutide or tirzepatide is usually fulfilled by a licensed compounding pharmacy — either a 503A (patient-specific) or 503B (outsourcing facility) operation.

Most telehealth platforms ship directly to your door. Expect cold-pack shipping for injectable medications, which need to be refrigerated. The fastest platforms can get medication to you within 2–3 business days of prescription approval; slower platforms may take 7–14 days depending on pharmacy backlog.

Step 4: Dose Titration and Follow-Up

GLP-1 therapy isn't a one-and-done prescription. Every FDA-approved GLP-1 uses a titration schedule — starting at a low dose and gradually increasing over weeks or months. For semaglutide, the standard titration starts at 0.25mg weekly for 4 weeks, then increases to 0.5mg, 1mg, 1.7mg, and eventually 2.4mg (for Wegovy's weight loss indication).

A quality telehealth platform builds this titration into your care plan. That means scheduled check-ins — typically monthly — where your provider assesses your tolerance, manages side effects, and adjusts your dose. Platforms that prescribe a high dose from day one or don't offer follow-up should be avoided.

Step 5: Ongoing Management

GLP-1 treatment is typically long-term. Clinical trials show that patients who stop semaglutide regain roughly two-thirds of lost weight within a year. That means your telehealth relationship isn't temporary — it's an ongoing medical partnership. The best platforms offer continuous access to your care team, refill coordination without gaps, switching between medications if one isn't working, and lifestyle guidance alongside pharmacotherapy.

This is also where the difference between a "prescription mill" and a real telehealth program becomes clear. If your provider hasn't checked in after three months, or if there's no process for adjusting your treatment plan, it's time to switch.

What About Lab Work?

Some platforms require labs before prescribing; others don't. There's an argument for both approaches. The American Association of Clinical Endocrinology recommends baseline labs including a metabolic panel and thyroid function tests before starting GLP-1 therapy. However, many telehealth platforms have found that requiring labs upfront creates a barrier to access — patients drop off before completing the process.

The emerging consensus in 2026 is that labs are strongly recommended but not universally required for otherwise healthy patients seeking compounded GLP-1s. If you have pre-existing conditions (diabetes, kidney disease, thyroid issues), labs should be non-negotiable before starting treatment.